Simulations Plus Upgrades PKPlus™
Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced the launch of version 2.5 of PKPlus, an update to its software for analysis of preclinical and clinical trial data.
Mark Pflieger, product manager for PKPlus, said: “We delivered several important enhancements, including the simplification of pharmacokinetic (PK) data analyses, as well as automating and streamlining key routines. Special thanks to the dedicated team at Simulations Plus and those clients that provided important feedback for all their efforts.”
New features and enhancements of PKPlus 2.5 include:
- Import CDISC SEND packages with PC domain as source data
- Improved command line functionality
- 64-bit system optimization for improved performance
- Streamlined auto-reports
- Additional workflow refinements
John DiBella, president of the Lancaster division for Simulations Plus, added: “As the client base for PKPlus has grown, we have engaged with users to identify the core functionality that they need to support the vast majority of their research activities. Throughout this effort, we’ve been, and continue to be, laser-focused on making our clients’ jobs easier with the enhancements in this new release. The demand for an affordable, commercially supported PK modeling platform remains strong, and we look forward to getting this version into the hands of industry scientists and students alike.”
View on demand the exciting new features in PKPlus 2.5 in the webinars section of the Simulations Plus website. In our commitment to support future generations of PK modelers, we continue to offer this version at no cost for academic institutions.